KR100737191B1 - 고융점 결정 변형체인 에피나스틴 하이드로클로라이드의제조방법 - Google Patents

고융점 결정 변형체인 에피나스틴 하이드로클로라이드의제조방법 Download PDF

Info

Publication number
KR100737191B1
KR100737191B1 KR1020027007120A KR20027007120A KR100737191B1 KR 100737191 B1 KR100737191 B1 KR 100737191B1 KR 1020027007120 A KR1020027007120 A KR 1020027007120A KR 20027007120 A KR20027007120 A KR 20027007120A KR 100737191 B1 KR100737191 B1 KR 100737191B1
Authority
KR
South Korea
Prior art keywords
hydrochloric acid
temperature
process according
aqueous phase
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020027007120A
Other languages
English (en)
Korean (ko)
Other versions
KR20020058080A (ko
Inventor
다흐롤프
Original Assignee
베링거 잉겔하임 파르마 게엠베하 운트 코 카게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 filed Critical 베링거 잉겔하임 파르마 게엠베하 운트 코 카게
Publication of KR20020058080A publication Critical patent/KR20020058080A/ko
Application granted granted Critical
Publication of KR100737191B1 publication Critical patent/KR100737191B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
KR1020027007120A 1999-12-03 2000-11-29 고융점 결정 변형체인 에피나스틴 하이드로클로라이드의제조방법 Expired - Lifetime KR100737191B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19958460.5 1999-12-03
DE19958460A DE19958460A1 (de) 1999-12-03 1999-12-03 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation

Publications (2)

Publication Number Publication Date
KR20020058080A KR20020058080A (ko) 2002-07-12
KR100737191B1 true KR100737191B1 (ko) 2007-07-10

Family

ID=7931396

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027007120A Expired - Lifetime KR100737191B1 (ko) 1999-12-03 2000-11-29 고융점 결정 변형체인 에피나스틴 하이드로클로라이드의제조방법

Country Status (23)

Country Link
US (1) US6403790B1 (enExample)
EP (1) EP1237892B1 (enExample)
JP (1) JP4789383B2 (enExample)
KR (1) KR100737191B1 (enExample)
CN (1) CN1402728A (enExample)
AR (1) AR026678A1 (enExample)
AT (1) ATE238306T1 (enExample)
AU (1) AU2163501A (enExample)
BR (1) BR0016052A (enExample)
CA (1) CA2389170C (enExample)
CO (1) CO5251470A1 (enExample)
CZ (1) CZ20021843A3 (enExample)
DE (2) DE19958460A1 (enExample)
DK (1) DK1237892T3 (enExample)
EA (1) EA200200630A1 (enExample)
ES (1) ES2198368T3 (enExample)
HU (1) HUP0203501A2 (enExample)
IL (1) IL149711A0 (enExample)
MX (1) MXPA02005330A (enExample)
PL (1) PL355628A1 (enExample)
PT (1) PT1237892E (enExample)
UY (1) UY26461A1 (enExample)
WO (1) WO2001040229A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
MXPA05000071A (es) * 2002-08-02 2005-04-08 Boehringer Ingelheim Int Combinaciones de epinastina, pseudoefedrina y metilefedrina como nuevas formulaciones farmaceuticas.
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13ｂ디하이드로-1Ｈ-디벤즈-[ｃ,ｆ]이미다조[1,5-ａ]-아제핀 염산염의 제조방법
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035749A1 (de) * 1980-03-08 1981-09-16 C.H. Boehringer Sohn Heterocyclische Verbindungen, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0496306A1 (de) * 1991-01-25 1992-07-29 Boehringer Ingelheim Kg Verfahren zur Herstellung von 3-Amino-9,13b-dihydro-1H-dibenz-[c,f]imidazol[1,5-a]azepin-hydrochlorid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3726291B2 (ja) * 1993-07-05 2005-12-14 三菱ウェルファーマ株式会社 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
JPH083160A (ja) * 1994-06-22 1996-01-09 Nippon Kayaku Co Ltd ６−（１−ｈ−イミダゾール−１−イル）−７−ニトロ−２，３−（１ｈ，４ｈ）−キノキサリンジオン塩酸塩又は硫酸塩の分離精製法
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
JPH0948765A (ja) * 1995-08-04 1997-02-18 Toyama Chem Co Ltd 安定な結晶構造を有するトリアゾール誘導体およびその製造法
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035749A1 (de) * 1980-03-08 1981-09-16 C.H. Boehringer Sohn Heterocyclische Verbindungen, ihre Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0496306A1 (de) * 1991-01-25 1992-07-29 Boehringer Ingelheim Kg Verfahren zur Herstellung von 3-Amino-9,13b-dihydro-1H-dibenz-[c,f]imidazol[1,5-a]azepin-hydrochlorid

Also Published As

Publication number Publication date
EP1237892A2 (de) 2002-09-11
CO5251470A1 (es) 2003-02-28
ES2198368T3 (es) 2004-02-01
EP1237892B1 (de) 2003-04-23
AR026678A1 (es) 2003-02-19
DK1237892T3 (da) 2003-08-04
CN1402728A (zh) 2003-03-12
JP4789383B2 (ja) 2011-10-12
UY26461A1 (es) 2001-07-31
WO2001040229A3 (de) 2001-12-06
KR20020058080A (ko) 2002-07-12
AU2163501A (en) 2001-06-12
DE19958460A1 (de) 2001-06-07
CA2389170A1 (en) 2001-06-07
ATE238306T1 (de) 2003-05-15
JP2003515536A (ja) 2003-05-07
PT1237892E (pt) 2003-08-29
CA2389170C (en) 2008-01-08
CZ20021843A3 (cs) 2002-08-14
IL149711A0 (en) 2002-11-10
PL355628A1 (en) 2004-05-04
BR0016052A (pt) 2002-07-23
EA200200630A1 (ru) 2002-12-26
HUP0203501A2 (hu) 2003-03-28
US6403790B1 (en) 2002-06-11
MXPA02005330A (es) 2003-01-28
WO2001040229A2 (de) 2001-06-07
DE50001920D1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
HU205754B (en) Process for producing ascorbic acid
KR100737191B1 (ko) 고융점 결정 변형체인 에피나스틴 하이드로클로라이드의제조방법
HU189641B (en) Process for preparing l-ascorbic acid
CN109575048B (zh) 一种头孢噻肟钠的制备方法
JP2000509068A (ja) エナンチオマーとして純粋なアゼチジン―２―カルボン酸の改良された製造方法
US4282161A (en) Novel purification process
HUE028377T2 (en) Method for cleaning mesotrione
US6987185B2 (en) Method for separating methyl 4-(2-chloro-4-fluorophenyl)-2-(3,5-difluoro-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrimidine-carboxylate-recemate
JPH11508589A (ja) エナンチオマーとして純粋なアゼチジン−２−カルボン酸の製造方法
JP3521242B2 (ja) ビスクレゾール類の精製方法
US20040210050A1 (en) Process for the preparation of highly pure cefuroxime axetil
JPH03240793A (ja) アンフォテリシンｂの精製方法および組成物
JP2001226372A (ja) ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法
WO2003104180A1 (en) Process for the preparation of 4-(4-fluorobenzoyl) butyric acid
EP1768980B1 (en) Improved process for the manufacture of mirtazapine
US5523423A (en) Form of form 1 Ranitidine
US20090048463A1 (en) Process for the manufacture of iohexol
JP4514017B2 (ja) 塩酸エピナスチンの製造方法
EP0441760B1 (en) Purification process for N,N-diethylmandelamide
US5264653A (en) Process for purifying 1,1,3,4,4,6-hexamethyltetralin
JP2957273B2 (ja) ７―クロル―キノリン―８―カルボン酸の精製方法
JP3523661B2 (ja) ２−アルキル−４−ハロゲノ−５−ホルミルイミダゾールの精製方法
JP2003518133A (ja) ９−デオキソ−９（ｚ）−ヒドロキシイミノエリスロマイシンａを製造、単離する方法
JPH10512895A (ja) 精製方法
JPH09227569A (ja) ５−（５−オキソヘキサヒドロ−１Ｈ−チエノ〔３，４−ｄ〕イミダゾール−１−イル）ペンタン酸の回収方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20020603

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20051129

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20061114

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20070409

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20070703

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20070704

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20100630

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20110627

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20120625

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20130621

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20130621

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20140623

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20140623

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20150626

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20150626

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20160628

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20160628

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20170623

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20170623

Start annual number: 11

End annual number: 11

PC1801 Expiration of term

Termination date: 20210529

Termination category: Expiration of duration